Alzheimer's disease is more prevalent in these parts of the US

Indonesia Berita Berita

Alzheimer's disease is more prevalent in these parts of the US
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 wrtv
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

A new study looked into the prevalence of Alzheimer's disease by county.

There are more people with Alzheimer's disease living in the eastern and southeastern parts of the U.S., a study published Monday in The Journal of the Alzheimer's Association found.

It concluded states with more people older than 85, more women and more minorities — specifically Black people — had a higher prevalence of Alzheimer's disease. By county, the study found Florida's Miami-Dade County, Maryland's Baltimore City and New York's Bronx County had the highest Alzheimer's prevalence rates, each with 16.6% of residents above 65 having the disease.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

wrtv /  🏆 598. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskSecond Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskNew research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening.
Baca lebih lajut »

Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskSecond Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskAnother experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Baca lebih lajut »

Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskSecond Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskNew research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening.
Baca lebih lajut »

Gene-Editing Tools Pave Way for New Alzheimer's TreatmentsGene-Editing Tools Pave Way for New Alzheimer's TreatmentsTwo new studies using CRISPR gene editing offer potential new treatments for Alzheimer's disease.
Baca lebih lajut »

Second Alzheimer’s drug in pipeline can slow the disease by a few months but with safety riskSecond Alzheimer’s drug in pipeline can slow the disease by a few months but with safety riskAnother experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Baca lebih lajut »

Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskSecond Alzheimer's drug in pipeline can slow the disease by a few months but with safety riskNew research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening.
Baca lebih lajut »



Render Time: 2025-03-13 01:31:26